Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Regeneron Pharmaceuticals Inc., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Regeneron Pharmaceuticals Inc. June 12, 202697.4%
-
Regeneron Pharmaceuticals Inc. June 9, 202396.3%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Nov 3, 2026 | Regeneron Pharmaceuticals Inc. | Option exercise | +7,439 | $380.95 | $2,833,887 |
| Nov 3, 2026 | Regeneron Pharmaceuticals Inc. | Open-market sale | −6,939 | $970.42 | $6,733,744 |
| Nov 3, 2026 | Regeneron Pharmaceuticals Inc. | Open-market sale | −500 | $971.06 | $485,530 |
| Aug 10, 2026 | Regeneron Pharmaceuticals Inc. | Option exercise | +800 | $376.69 | $301,352 |
| Aug 10, 2026 | Regeneron Pharmaceuticals Inc. | Open-market sale | −800 | $800.00 | $640,000 |
| Feb 19, 2026 | Regeneron Pharmaceuticals Inc. | Option exercise | +1,638 | $376.69 | $617,018 |
| Feb 19, 2026 | Regeneron Pharmaceuticals Inc. | Open-market sale | −49 | $774.68 | $37,959 |
| Feb 19, 2026 | Regeneron Pharmaceuticals Inc. | Open-market sale | −50 | $775.50 | $38,775 |
| Feb 19, 2026 | Regeneron Pharmaceuticals Inc. | Open-market sale | −53 | $778.47 | $41,259 |
| Feb 19, 2026 | Regeneron Pharmaceuticals Inc. | Open-market sale | −208 | $779.55 | $162,146 |
| Feb 19, 2026 | Regeneron Pharmaceuticals Inc. | Open-market sale | −331 | $780.45 | $258,329 |
| Feb 19, 2026 | Regeneron Pharmaceuticals Inc. | Open-market sale | −209 | $781.28 | $163,288 |
| Feb 19, 2026 | Regeneron Pharmaceuticals Inc. | Open-market sale | −298 | $782.10 | $233,066 |
| Feb 19, 2026 | Regeneron Pharmaceuticals Inc. | Open-market sale | −220 | $783.29 | $172,324 |
| Feb 19, 2026 | Regeneron Pharmaceuticals Inc. | Open-market sale | −160 | $784.45 | $125,512 |
Questions about Huda Y. Zoghbi
What boards is Huda Y. Zoghbi on?
Huda Y. Zoghbi sits on the board of Regeneron Pharmaceuticals Inc.
How long has Huda Y. Zoghbi served on boards?
Our records show at least 4 years of board service across 1 board, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.